Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance

被引:13
作者
Carrion-Penagos, Julian [1 ]
Zeineddine, Hussein A. [1 ]
Polster, Sean P. [1 ]
Girard, Romuald [1 ]
Lyne, Sean B. [1 ]
Koskimaki, Janne [1 ]
Romanos, Sharbel [1 ]
Srinath, Abhinav [1 ]
Zhang, Dongdong [1 ]
Cao, Ying [1 ]
Stadnik, Agnieszka [1 ]
Piedad, Kristina [1 ]
Shenkar, Robert [1 ]
Awad, Issam A. [1 ]
机构
[1] Univ Chicago Med & Biol Sci, Dept Surg, Sect Neurosurg, Neurovasc Surg Program, Chicago, IL USA
关键词
cerebral cavernous hemangioma; intracranial hemorrhage; cerebrovascular disorders; magnetic resonance imaging; natural history; vascular disorders; OCCULT VASCULAR MALFORMATIONS; FOLLOW-UP; ASYMPTOMATIC PATIENTS; SOMATIC MUTATIONS; NATURAL-HISTORY; CLINICAL-COURSE; METAANALYSIS; HEMORRHAGE; PATHWAY; BRAIN;
D O I
10.3171/2020.1.JNS193479
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE The purpose of this study was to systematically assess asymptomatic changes (ACs), including subclinical hemorrhage, growth, or new lesion formation (NLF) during longitudinal follow-up of cerebral cavernous angiomas (CAs), and to correlate these with symptomatic hemorrhage (SH) during the same period and with clinical features of the disease. METHODS One hundred ninety-two patients were included in this study, among 327 consecutive patients with CA, prospectively identified between September 2009 and February 2019. Included patients had undergone clinical and MRI follow-up, in conjunction with institutional review board-approved biomarker studies, and harbored >= 1 CA with a maximum diameter of >= 5 mm on T2-weighted MRI. Rates of AC and SH per lesion-year and patient-year were assessed using prospectively articulated criteria. In multifocal/familial cases, rates of NLF were also assessed. RESULTS There were no differences in demographic or disease features among cases included or excluded in the study cohort, except for a higher proportion of included patients with CCM3 mutation. Follow-up was 411 patient-years (2503 lesion-years). The rate of AC was higher than the rate of SH (12.9% vs 7.5% per patient-year, and 2.1% vs 1.2% per lesion-year, both p = 0.02). Patients presenting with a prior history of SH had a higher rate of AC than those with other forms of presentation (19.7% and 8.2% per patient-year, respectively; p = 0.003). A higher rate of NLF on T2-weighted MRI (p = 0.03) was observed in patients with prior SH. Three of 6 solitary/sporadic and 2 of 28 multifocal/familial patients underwent resection of the lesion after AC. CONCLUSIONS Rates of AC are greater than SH during prospective follow-up of CAs, and greater in cases with prior SH. AC may be a more sensitive biomarker of lesional activity, and a more efficient surrogate outcome in clinical trials than SH. Patients experiencing an AC are more likely to undergo a surgical intervention when CAs are solitary/sporadic than when they are multifocal/familial.
引用
收藏
页码:1147 / 1154
页数:8
相关论文
共 27 条
  • [1] Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel
    Akers, Amy
    Salman, Rustam Al-Shahi
    Awad, Issam A.
    Dahlem, Kristen
    Flemming, Kelly
    Hart, Blaine
    Kim, Helen
    Jusue-Torres, Ignacio
    Kondziolka, Douglas
    Lee, Cornelia
    Morrison, Leslie
    Rigamonti, Daniele
    Rebeiz, Tania
    Tournier-Lasserve, Elisabeth
    Waggoner, Darrel
    Whitehead, Kevin
    [J]. NEUROSURGERY, 2017, 80 (05) : 665 - 679
  • [2] Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis
    Akers, Amy L.
    Johnson, Eric
    Steinberg, Gary K.
    Zabramski, Joseph M.
    Marchuk, Douglas A.
    [J]. HUMAN MOLECULAR GENETICS, 2009, 18 (05) : 919 - 930
  • [3] Natural history and imaging prevalence of cavernous malformations in children and young adults Clinical article
    Al-Holou, Wajd N.
    O'Lynnger, Thomas M.
    Pandey, Aditya S.
    Gemmete, Joseph J.
    Thompson, B. Gregory
    Muraszko, Karin M.
    Garton, Hugh J. L.
    Maher, Cormac O.
    [J]. JOURNAL OF NEUROSURGERY-PEDIATRICS, 2012, 9 (02) : 198 - 205
  • [4] Cavernous angiomas: deconstructing a neurosurgical disease
    Awad, Issam A.
    Polster, Sean P.
    [J]. JOURNAL OF NEUROSURGERY, 2019, 131 (01) : 1 - 13
  • [5] Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed
    Baumann, CR
    Schuknecht, B
    Lo Russo, G
    Cossu, M
    Citterio, A
    Andermann, F
    Siegel, AM
    [J]. EPILEPSIA, 2006, 47 (03) : 563 - 566
  • [6] Magnetic Resonance Imaging Evaluation of Cerebral Cavernous Malformations With Susceptibility-Weighted Imaging
    de Champfleur, Nicolas Menjot
    Langlois, Christophe
    Ankenbrandt, William J.
    Le Bars, Emmanuelle
    Leroy, Marie Anne
    Duffau, Hugues
    Bonafe, Alain
    Jaffe, Jennifer
    Awad, Issam A.
    Labauge, Pierre
    [J]. NEUROSURGERY, 2011, 68 (03) : 641 - 647
  • [7] Susceptibility-weighted Imaging for the evaluation of patients with familial cerebral cavernous malformations: A comparison with T2-weighted fast spin-echo and gradient-echo sequences
    de Souza, J. M.
    Domingues, R. C.
    Cruz, L. C. H.
    Domingues, F. S.
    Lasbeck, T.
    Gasparetto, E. L.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (01) : 154 - 158
  • [8] Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion
    Gault, J
    Shenkar, R
    Recksiek, P
    Awad, IA
    [J]. STROKE, 2005, 36 (04) : 872 - 874
  • [9] CEREBRAL CAVERNOUS MALFORMATIONS: SOMATIC MUTATIONS IN VASCULAR ENDOTHELIAL CELLS
    Gault, Judith
    Awad, Issam A.
    Recksiek, Peter
    Shenkar, Robert
    Breeze, Robert
    Handler, Michael
    Kleinschmidt-DeMasters, Bette K.
    [J]. NEUROSURGERY, 2009, 65 (01) : 138 - 145
  • [10] Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations
    Girard, Romuald
    Fam, Maged D.
    Zeineddine, Hussein A.
    Tan, Huan
    Mikati, Abdul Ghani
    Shi, Changbin
    Jesselson, Michael
    Shenkar, Robert
    Wu, Meijing
    Cao, Ying
    Hobson, Nicholas
    Larsson, Henrik B. W.
    Christoforidis, Gregory A.
    Awad, Issam A.
    [J]. JOURNAL OF NEUROSURGERY, 2017, 127 (01) : 102 - 110